GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $280,000 | -3.4% | 7,340 | +9.1% | 0.03% | -38.2% |
| Q2 2017 | $290,000 | -27.9% | 6,730 | -35.5% | 0.06% | -49.1% |
| Q4 2016 | $402,000 | +67.5% | 10,428 | +75.4% | 0.11% | +50.0% |
| Q4 2015 | $240,000 | -46.5% | 5,944 | -33.5% | 0.07% | -90.6% |
| Q3 2013 | $449,000 | +55.9% | 8,945 | +41.5% | 0.77% | +3.8% |
| Q2 2012 | $288,000 | – | 6,321 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |